홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Diclofenac sodium → Diclofenac

HRID 990889
인쇄

반응식

HRID 990889 반응식
C(O)(=O)CCCCCCCCCCC/C=C\CCCCCCCC.[CH:25]1[CH:30]=[C:29]([CH2:31][C:32]([O-:34])=[O:33])[C:28]([NH:35][C:36]2[C:41]([Cl:42])=[CH:40][CH:39]=[CH:38][C:37]=2[Cl:43])=[CH:27][CH:26]=1.[Na+]>C(O)C>[CH:25]1[CH:26]=[CH:27][C:28]([NH:35][C:36]2[C:41]([Cl:42])=[CH:40][CH:39]=[CH:38][C:37]=2[Cl:43])=[C:29]([CH2:31][C:32]([OH:34])=[O:33])[CH:30]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 5018304Diclofenac sodiumHCID 5281116Erucic Acid2회

생성물 1

HCID 3033Diclofenac

시약·촉매·용매 1

HCID 702Ethanol용매

실험 절차

A rectal suppository comprising erucic acid, beeswax, and the medicine diclofenac was prepared as follows: About 8.08 kg of micronized sodium diclofenac was added to a homogenous melt containing about 122.34 kg of erucic acid and about 13.57 kg of beeswax at a temperature of about 75° C. The medicine and suppository base was mixed gently until homogenous and the ethanol evaporated then poured into a mold. Upon cooling the suppository was removed from the mold.

후처리

  1. customevaporated
  2. additionthen poured into a mold
  3. temperatureUpon cooling the suppository
  4. customwas removed from the mold

출처 및 근거

ORD 기록
ord-481f1ea819d34825855d9335b98da7be
출처 데이터셋
uspto-grants-2002_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06462083B1

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트